E
Canna 8 Investment Trust RCRP.V
TSX
Recommendation
Dividend Power Score
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

Canna 8 Investment Trust is a Canada-based investment issuer listed on the TSX Venture Exchange under the symbol RCRP.V. The company operates primarily as an investment and capital allocation vehicle with a focus on opportunities within the cannabis, healthcare, and adjacent regulated consumer sectors. Rather than operating as a plant-touching cannabis company, Canna 8’s model centers on deploying capital into public and private entities through equity investments, structured financings, and strategic holdings.

The company was established to provide investors with diversified exposure to emerging growth sectors, particularly where regulatory change or consolidation creates investment opportunities. Its positioning emphasizes portfolio diversification and active investment management rather than direct operational control. Public disclosures indicate that the company has evolved through changes in strategy and asset composition, reflecting broader volatility and maturation within the cannabis investment landscape.

Business Operations

Canna 8 does not report traditional operating segments; instead, its business activities are organized around an investment portfolio model. Revenue generation, where applicable, is derived from realized and unrealized gains on investments, interest income, and other investment-related returns. The company’s assets typically consist of minority equity stakes, convertible instruments, or other financial interests in early-stage or publicly traded companies.

Operations are primarily domestic to Canada, with investments occasionally extending to international issuers depending on opportunity and regulatory constraints. The company does not control proprietary technologies or large operating assets and relies on external management teams of portfolio companies to execute underlying business strategies. Based on publicly available filings, there are no consistently disclosed material joint ventures or operating subsidiaries; data inconclusive based on available public sources.

Strategic Position & Investments

Strategically, Canna 8 positions itself as an opportunistic investor targeting undervalued or high-growth companies within regulated or transitioning industries. Its stated direction emphasizes capital preservation alongside selective growth, with investment decisions influenced by market dislocations, regulatory developments, and management quality of target companies.

Public disclosures reference historical and current investments in cannabis-related and health-oriented businesses; however, the composition of the portfolio has changed over time, and specific holdings are not always consistently reported across periods. There is no verified evidence of large-scale acquisitions or controlling interests in operating companies. Involvement in emerging technologies or sectors beyond cannabis and healthcare cannot be conclusively verified based on available public sources.

Geographic Footprint

The company is headquartered in Canada and maintains its primary market presence within North America. Its listing on the TSX Venture Exchange anchors its investor base and regulatory oversight in the Canadian capital markets.

While some portfolio investments may have international operations or exposure, Canna 8 itself does not report dedicated offices or operating infrastructure outside Canada. Any broader geographic influence is indirect, arising through minority investments rather than direct international operations; data inconclusive based on available public sources.

Leadership & Governance

Canna 8 is governed by a board of directors and managed by an executive team responsible for capital allocation, compliance, and investor reporting. Leadership’s stated focus centers on disciplined investment selection, risk management, and adapting strategy to evolving regulatory and market conditions.

Key executives and directors disclosed in public filings include:

  • Christopher ParryChief Executive Officer
  • Christopher ParryDirector
  • Additional directors and officers – Titles and roles vary by reporting period; data inconclusive based on available public sources regarding consistent executive appointments and tenure

The company operates under Canadian public company governance standards applicable to TSX Venture Exchange issuers, with oversight responsibilities divided between management and the board.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $174.40
B
AAPL NASDAQ $253.79
B
AVGO NASDAQ $309.51
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $124.28
B
Top Financial Stocks
See All »
B
B
JPM NYSE $294.16
B
V NYSE $302.24
Top Energy Stocks
See All »
Top Health Care Stocks
See All »
B
LLY NYSE $919.77
B
JNJ NYSE $244.44
B
AMGN NASDAQ $351.85
Top Real Estate Stocks
See All »
B
PLD NYSE $132.18